Cholesterol drugs do more than move numbers. This deep dive into bempedoic acid explores a newly discovered PPARα mechanism, ...

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

Gene editing reduced cholesterol by about 50% in an extremely small sample of patients over a year of follow-up, according to ...

Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain ...

Once-Monthly Injection Reduced Triglycerides and the Risk of Acute Pancreatitis; Bi-Weekly Injection Lowered "Bad" Cholesterol and Cardiovascular Events People living with diabetes are nearly 75% more ...

The new guidelines present a newly aggressive playbook for managing cholesterol that emphasizes earlier screenings and ...

European regulators have backed three new cholesterol-lowering therapies, potentially widening treatment options for patients who remain above low-density lipoprotein cholesterol (LDL-C) goals despite ...

Evolocumab, a cholesterol-lowering drug typically reserved for people with known cardiovascular disease, reduces risk of first-time heart attack and stroke in high-risk patients with diabetes. The ...

The Food and Drug Administration has approved a new kind of drug to cut cholesterol. So we've called up NPR health correspondent Rob Stein to learn what it can do. Good morning, Rob. ROB STEIN, BYLINE ...

A new study gives you one more reason to enjoy some avocado toast.